This post is from a suggested group
Restoring Bone Health: Analyzing the Etiology, Diagnostic Gaps, and Therapeutic Advances in the Global Avascular Necrosis (AVN) Market
The Avascular Necrosis (AVN), or osteonecrosis, market is focused on managing a painful and debilitating condition caused by the temporary or permanent loss of blood supply to a segment of bone, most commonly affecting the femoral head (hip), leading to bone cell death and eventual joint collapse. Market growth is being fueled by the increasing prevalence of known risk factors, including high-dose corticosteroid use, excessive alcohol consumption, and systemic conditions such as sickle cell disease and lupus. The clinical challenge is significant, as AVN is often asymptomatic in its early stages, delaying diagnosis until the disease has progressed to irreversible collapse of the articular surface, at which point the only definitive treatment is often total joint replacement. Consequently, the market is broadly divided between early-stage interventions designed to promote revascularization—such as core…